Contact information
Podcast Interview
Colleges
Dr Gail Carson
OBE
DIRECTOR OF NETWORK DEVELOPMENT, ISARIC
- Chair of the Global Outbreak Alert and Response Network (GOARN) 2022- 2024
- Chair of WHO EURO Preparedness TAG 2023 - 2024
- Deputy Chair GOARN 2018-2022
- GOARN research lead 2017 - 2020
Preparedness and response
ISARIC
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is a network of networks that was established in 2011 to ensure a rapid research response to outbreaks of pandemic potential. Having experienced the 2009 pandemic, SARS, and other outbreaks, many of ISARIC’s founding investigators acknowledged the need for a multidisciplinary and global approach that would encourage preparedness and collaboration in the interpandemic period. I left a job in public health to help set up ISARIC and have never looked back as it continues to grow and grow.
ISARIC has, to date, gathered 70 networks, with hospital based research sites in over 130 countries. All of whom are directly involved with outbreak response and preparedness locally, regionally, and internationally. Our membership includes clinicians, clinical researchers, clinical trials professionals, virologists, microbiologists, geneticists, epidemiologists and public health professionals, data analysts, statisticians, and ethicists among others.
During the 12 years+ at Oxford. I have worked with GloPID R (research funders consortium), WHO EURO, WHO Geneva, GOARN, Oxford University Business school and many others. My interest includes how to develop a strategy that supports preparedness, response and resilience.
Recent publications
-
Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
Pazukhina E. et al, (2024), BMC medicine, 22
-
A multi-country analysis of COVID-19 hospitalizations by vaccination status
Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2
-
A review of new challenges and solutions to the timely and effective implementation of clinical research responses to high priority diseases of epidemic and pandemic potential: A scoping review protocol
Kadri-Alabi Z. et al, (2023), Open Research Europe, 3, 139 - 139
-
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.
Roper KJ. et al, (2023), Scientific reports, 13
-
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376